Aortic Atherosclerosis as an Embolic Source

Sep 18, 2016 by in PHARMACY Comments Off on Aortic Atherosclerosis as an Embolic Source

Imaging modality Setting (labs vs intensive care units, interventional or operating room) Feasibility (selective criteria; renal function) Accuracy in wall evaluation and non mobile atheroma Accuracy in wall evaluation and…

read more

Medical Treatment in Chronic Aortic Dissection

Sep 18, 2016 by in PHARMACY Comments Off on Medical Treatment in Chronic Aortic Dissection

Figure 6.1 DeBakey and Stanford classification of aortic dissection. The DeBakey classification system categorizes dissections based on the origin of the intimal tear and the extent of the dissection: Type…

read more

Acute Aortic Syndrome: Medical Management

Sep 18, 2016 by in PHARMACY Comments Off on Acute Aortic Syndrome: Medical Management

Figure 5.1 Aortic dissection classification: DeBakey and Stanford classification as the currently most frequently used classification systems for aortic dissection Prevalence of Risk Factors Aortic dissection and its variants are…

read more

Aortitis

Sep 18, 2016 by in PHARMACY Comments Off on Aortitis

Non-infectious a Associated with vasculitides  With large-vessel vasculitis   Giant cell arteritisb   Takayasu arteritisb  With variable vessel vasculitis   Cogan’s syndromeb   Behçet’s diseasec  With medium- and small-vessel vasculitis   Polyarteritis nodosad   Wegener arteritisd…

read more

Marfan Syndrome

Sep 18, 2016 by in PHARMACY Comments Off on Marfan Syndrome

Absence of family history Aortic root dilatationa or aortic root dissection AND ectopia lentis Aortic root dilatationa or aortic root dissection AND FBN1 mutation Aortic root dilatationa or aortic root…

read more

Receptors and Itch

Sep 18, 2016 by in PHARMACY Comments Off on Receptors and Itch

Fig. 1 Schematic diagram of origins of PAR ligands in the skin. Figure shows cross section through the skin. The proteases originate from endogenous sources including keratinocytes and immune cells…

read more

Opioid-Induced Itch and Its Pharmacological Antagonism

Sep 18, 2016 by in PHARMACY Comments Off on Opioid-Induced Itch and Its Pharmacological Antagonism

Neuraxial opioids Treatment drug and doses Outcomes and conclusion References Intrathecal morphine 10–320 μg Intravenous nalmefene (MOP antagonist) 10–32 μg/kg Effective Scratching responses: ↓ Ko and Naughton (2000) Intrathecal morphine 32 μg Intramuscular…

read more

and Its Inhibition by Counter Stimuli

Sep 18, 2016 by in PHARMACY Comments Off on and Its Inhibition by Counter Stimuli

Fig. 1 Sharpening sensory acuity through lateral interaction. In the visual system, a center-surround receptive field sharpens the spatial input for visual acuity. By analogy, a stimulus-counter-stimulus receptive field may…

read more
Get Clinical Tree app for offline access